Primecap Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-295,070
| Closed | -$15.5M | – | 329 |
|
|
2020
Q3 | $15.5M | Sell |
295,070
-63,770
| -18% | -$2.64M | 0.01% | 227 |
|
|
2020
Q2 | $11.9M | Sell |
358,840
-31,240
| -8% | -$995K | 0.01% | 226 |
|
|
2020
Q1 | $10.6M | Sell |
390,080
-2,359,320
| -86% | -$65.7M | 0.01% | 215 |
|
|
2019
Q4 | $54.2M | Hold |
2,749,400
| – | – | 0.04% | 169 |
|
|
2019
Q3 | $35.6M | Sell |
2,749,400
-336,500
| -11% | -$4.06M | 0.03% | 180 |
|
|
2019
Q2 | $38.4M | Buy |
3,085,900
+5,240
| +0.2% | +$69.6K | 0.03% | 192 |
|
|
2019
Q1 | $44.8M | Buy |
3,080,660
+23,965
| +0.8% | +$306K | 0.03% | 187 |
|
|
2018
Q4 | $33.7M | Buy |
3,056,695
+168,595
| +6% | +$2.35M | 0.03% | 193 |
|
|
2018
Q3 | $76M | Hold |
2,888,100
| – | – | 0.05% | 158 |
|
|
2018
Q2 | $59.1M | Hold |
2,888,100
| – | – | 0.04% | 169 |
|
|
2018
Q1 | $52.4M | Buy |
2,888,100
+19,200
| +0.7% | +$320K | 0.04% | 173 |
|
|
2017
Q4 | $40M | Buy |
2,868,900
+30,000
| +1% | +$406K | 0.03% | 182 |
|
|
2017
Q3 | $52.5M | Sell |
2,838,900
-1,000
| -0% | -$16.7K | 0.04% | 172 |
|
|
2017
Q2 | $48M | Buy |
2,839,900
+100,000
| +4% | +$1.52M | 0.04% | 179 |
|
|
2017
Q1 | $36.6M | Hold |
2,739,900
| – | – | 0.03% | 185 |
|
|
2016
Q4 | $41.2M | Hold |
2,739,900
| – | – | 0.04% | 172 |
|
|
2016
Q3 | $32M | Buy |
2,739,900
+1,000
| +0% | +$11.8K | 0.03% | 183 |
|
|
2016
Q2 | $29.6M | Hold |
2,738,900
| – | – | 0.03% | 189 |
|
|
2016
Q1 | $25.3M | Hold |
2,738,900
| – | – | 0.03% | 192 |
|
|
2015
Q4 | $40.6M | Buy |
2,738,900
+38,000
| +1% | +$636K | 0.04% | 176 |
|
|
2015
Q3 | $44.3M | Hold |
2,700,900
| – | – | 0.05% | 170 |
|
|
2015
Q2 | $61.6M | Buy |
2,700,900
+5,800
| +0.2% | +$116K | 0.06% | 166 |
|
|
2015
Q1 | $41M | Buy |
2,695,100
+24,500
| +0.9% | +$318K | 0.04% | 178 |
|
|
2014
Q4 | $32.2M | Hold |
2,670,600
| – | – | 0.03% | 186 |
|
|
2014
Q3 | $30.3M | Hold |
2,670,600
| – | – | 0.03% | 184 |
|
|
2014
Q2 | $32.3M | Buy |
2,670,600
+511,186
| +24% | +$6.04M | 0.04% | 177 |
|
|
2014
Q1 | $25.2M | Buy |
2,159,414
+654,414
| +43% | +$11.1M | 0.03% | 180 |
|
|
2013
Q4 | $26.6M | Hold |
1,505,000
| – | – | 0.03% | 185 |
|
|
2013
Q3 | $21.7M | Buy |
1,505,000
+106,000
| +8% | +$1.62M | 0.03% | 185 |
|
|
2013
Q2 | $21.1M | Buy |
+1,399,000
| New | +$18.5M | 0.03% | 183 |
|
Primecap Management's MNTA Position: Q4 2020 in Review
Primecap Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 295,070 shares — an estimated $15.5M sold.
Primecap Management first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $76M in Q3 2018. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Primecap Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Primecap Management sold 295,070 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $15.5M.
- Primecap Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Primecap Management's Momenta Pharmaceuticals, Inc. position peaked at $76M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Primecap Management's 13F filing for Q4 2020, filed 8 Feb 2021.